Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
14421
Differences in cell death estimation between flow cytometry and holographic microscopy.
Published 2015“…For typical morphological criteria of oncotic/apoptic cells see (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0121674#pone.0121674.t001" target="_blank">Table 1</a>) <b>E</b>. Relative change of cell surface in individual cells (relative to initial time point). …”
-
14422
-
14423
DDB2, XPC and p53 follow same induction/translocation pattern after UV exposure in NHEK and HCEC.
Published 2016“…(B) Quantitative analysis of Western blots shows a rapid increase of DDB2 on the CB fraction and a (E) rapid decrease in NS post-UV irradiation (unirradiated control vs 0h post-UV) in both NHEK and HCEC. …”
-
14424
Reduced VEGF disrupts the parenchyma around airways and vasculature.
Published 2016“…(D, E) Representative images of Sirius red stain for Type 1 collagen demonstrates decreased peri-vascular staining in mutants (E) compared to controls (D). …”
-
14425
DataSheet_2_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14426
DataSheet_3_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14427
DataSheet_1_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14428
Video_1_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.mp4
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14429
DataSheet_4_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.xlsx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14430
DataSheet_3_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14431
Video_1_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.mp4
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14432
DataSheet_6_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14433
DataSheet_1_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14434
DataSheet_2_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14435
DataSheet_6_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14436
DataSheet_4_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.xlsx
Published 2021“…Twenty adult participants, i.e., 13 (65%) men and 7 (35%) women, with a median age of 44 years and a mean body surface area of 1.92 m<sup>2</sup> (median = 1.93 m<sup>2</sup>) were recruited. …”
-
14437
DAF-16 contributes to inhibition of <i>mec-4d</i>–dependent AVM degeneration associated with reduced IIS signaling.
Published 2013“…A strong signal of the dye co-localized with the endogeneous GFP expressed by degenerating TNRs. Scale bar, 5 µm. (F–G) <i>mec-4d</i> worms were treated from the time of hatching with the ROS scavenger trolox (100 µm) and ascorbic acid (AA, 50 mM); after 72 hours both somas (F) and axons (G) were protected several fold compared to control nematodes (mean value for each category is shown; error bars [<1%] not included; N = 3 of 30 worms each per group; *p<0.005 by Student's t test compared with control for the SoW and AxW category).…”
-
14438
Comprehensive gene expression analyses of differentiating ES cells.
Published 2013“…A subset of RA-responsive genes demonstrating a greater-than-2-fold decrease in the modified FPKM values in differentiating ΔSET ES cells was analyzed. …”
-
14439
Increased aerobic glycolysis in MADD fibroblasts and <i>xav</i> mutants.
Published 2009“…<b>E.</b> qRT-PCR analyses of gene expression revealed increased expression of glycolytic enzymes <i>eno1</i>, <i>pgam1a</i>, <i>pgk1</i>, <i>pfkma</i>, and <i>fructose-biphosphate aldolase C</i> (<i>aldoc</i>) by 2.8, 2, 1.9, 1.8 and 2.1 fold respectively, as well a ∼20% decrease in <i>dihydrolipoamide S-acetyltransferase</i> (<i>dlat</i>), that belongs to the pyruvate dehydrogenase complex, which links glycolysis to tricarboxylic acid (TCA) cycle, in <i>xav</i> mutants compared to WT embryos at ∼56 hpf (N = 3–7 replicates, 20 embryos each; Student's t test, * p<0.05, ** p<0.01).…”
-
14440
Table1_Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project.docx
Published 2023“…Three different questionnaires were included in the data collection (Katz ADL, EQ-5D-5l, PHQ-D).</p>Results<p>We included 285 TAVI patients in the analysis (mean age 79.8 years, 59.4% male, mean EuroSCORE II 3.8%). 30-day mortality was 3.6%, complications of any kind occurred in 18.9% of the patients. …”